Sapiens International Launches Automated Testing Services with Encova Insurance to Enhance Software Quality and Efficiency

Reuters
Sep 10, 2025
Sapiens International Launches Automated Testing Services with Encova Insurance to Enhance Software Quality and Efficiency

Sapiens International Corporation, a prominent provider of software solutions for the insurance sector, has announced the first implementation of its Automated Testing Services $(ATS)$ with Encova Insurance. This expansion of their partnership aims to streamline testing processes and improve software quality for Encova, a multi-line mutual insurer. The new ATS, integrated with Encova's CoreSuite for Workers' Compensation solution, is expected to significantly reduce testing time, enhance consistency in test coverage, and support faster software releases. By utilizing Microsoft Playwright and a custom framework, the service not only addresses the time-intensive demands of regression testing but also provides personalized support and training for Encova's customized codes. This initiative will empower Encova to upgrade more frequently, meet market demands swiftly, and focus on strategic priorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sapiens International Corporation NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-086363), on September 10, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10